Notch signaling molecules as prognostic biomarkers for nonsmall cell lung cancer

Author：        

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|5|3252-3260

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.5, 2015-01, pp. : 3252-3260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic significance of G2/M arrest signaling pathway proteins in advanced non-small cell lung cancer patients

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1266-1272

Spandidos Publications

Access to resources Recommend Favorite

ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway

By                    

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1709-1718

Spandidos Publications

Access to resources Recommend Favorite

Impact of biomarkers on non-small cell lung cancer treatment

By Toschi Luca  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 5-17

Springer Publishing Company

Access to resources Recommend Favorite

Complement component 3 is a prognostic factor of nonsmall cell lung cancer

By              

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 811-817

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance of SOX18 expression in non-small cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 123-132

Spandidos Publications

Access to resources Recommend Favorite